Skip To Main Content
Rachel Ryu on Muck Rack

Rachel Ryu

As seen in: Memory Studies, JAMA (The Journal of the American Medical Association), U.S. Pharmacist, Office Hours With EAB
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Rachel Ryu’s profile

Articles by Rachel Ryu

Adult learners: who they are and what they want out of college

|
By Rachel Ryu
| Office Hours With EAB
Over the last few years, colleges and universities have increasingly prioritized adult learner enrollment to offset declining undergraduate enrollment and diversify revenue streams. One hundred percent of surveyed presidents and provosts said adult learner enrollment is a high or moderate priority for their institution. And today, adult learners make up at least 40% of total higher ed revenue. We’ve rounded up a few quick facts about adult learners—check them out below.
Open in Who Shared Issue with article?

Brand marketing in higher education

|
By Rachel Ryu
| Office Hours With EAB
In my role as EAB’s CMO, I often feel caught between two competing imperatives: build brand awareness, affinity, and trust…or fill the funnel now. In some marketing circles, this is referred to as the “brand vs. demand” debate. And while few marketing leaders I know think this is actually an either-or choice, the tension is real. Why? Because budgets are finite, this year’s goals are looming, and attribution is hard. What are signs of this tension at play?
Open in Who Shared Issue with article?

Association Between Use of Angiotensin Receptor Blockers and Incidence of Epilepsy in Patients With Hypertension

|
By Rachel Ryu, Jonathan L. Kuo, Corinna Doege, Mark Luedde
| JAMA (The Journal of the American Medical Association) Verified
Association Between Use of Angiotensin Receptor Blockers and Incidence of Epilepsy in Patients With Hypertension To the Editor It is with great pleasure that we read the retrospective study by Doege et al,1 which found a reduced incidence of epilepsy in patients with hypertension receiving angiotensin receptor blockers (ARBs) compared with other antihypertensives. The risk was highest among patients receiving β-blockers and calcium channel blockers (CCBs).
Open in Who Shared Issue with article?

Critical Analysis of Apixaban Dose Adjustment Criteria

|
By Anh Vu, Ánh Vũ, Tao Qu, Rachel Ryu, Shuktika Nandkeolyar
| Memory Studies
Introduction Apixaban is a direct-acting oral anticoagulant (DOAC) initially approved in 2012 for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) and for the prevention and treatment of venous thromboembolism (VTE) in 2014. The dose adjustment criteria are not consistent across indications.
Open in Who Shared Issue with article?

Update on the Safety and Efficacy of Oral Anticoagulation in CKD and ESRD

|
By Rachel Ryu
| U.S. Pharmacist Verified
US Pharm. 2021;45(3)36-40. ABSTRACT: Atrial fibrillation (AF) is a supraventricular tachyarrhythmia that can cause stroke/systemic embolism (SE), and therefore, anticoagulation may be indicated. Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) may have greater risk for AF, stroke/SE, and bleeding, so the net benefit of anticoagulation is controversial.
Open in Who Shared Issue with article?
Show More